LivaNova (LIVN) Share-based Compensation Growth (1y) (2017 - 2026)
LivaNova (LIVN) Share-based Compensation Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.85 Bn | 194.25 Bn | 7.27 Bn | 18.31% |
| 2 | Stryker | 129.75 Bn | 126.28 Bn | 4.50 Bn | -78.13% |
| 3 | Medtronic | 119.86 Bn | 110.64 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 74.04 Bn | 73.50 Bn | 3.85 Bn | 16.00% |
| 5 | Edwards Lifesciences | 52.51 Bn | 48.26 Bn | 1.35 Bn | 12.53% |
| 6 | Dexcom | 34.75 Bn | 32.81 Bn | 830.00 Mn | -13.91% |
| 7 | GE HealthCare Technologies | 34.16 Bn | 32.05 Bn | 2.18 Bn | 60.71% |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 5.29% |
| 9 | Steris | 23.26 Bn | 22.78 Bn | 684.20 Mn | 7.56% |
| 10 | LivaNova | 4.32 Bn | 3.81 Bn | 273.67 Mn | 84.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 84.02% |
| Mar 31, 2026 | 6.26% |
| Dec 31, 2025 | -88.42% |
| Sep 30, 2025 | -102.99% |
| Jun 30, 2025 | -147.59% |
| Mar 31, 2025 | -23.89% |
| Dec 31, 2024 | -76.33% |
| Sep 30, 2024 | 641.68% |
| Jun 30, 2024 | 92.28% |
| Mar 31, 2024 | 548.45% |
| Dec 31, 2023 | 138.35% |
| Sep 30, 2023 | -89.24% |
| Jun 30, 2023 | -62.95% |
| Mar 31, 2023 | -84.62% |
| Dec 31, 2022 | 23.29% |
| Sep 30, 2022 | -3.55% |
| Jun 30, 2022 | 16.06% |
| Mar 31, 2022 | 7.55% |
| Dec 31, 2021 | 147.03% |
| Sep 30, 2021 | 42.39% |